The global peptide therapeutics market is expected to reach a value of US$23.7B by 2020 as a result of their efficacy for treating a huge array of conditions including cancer, metabolic disorders, nervous system disorders and gastrointestinal disorders among others. As such, further research has been done to develop a rich pipeline of novel peptides.
SMi’s CPD-certified conference provides the perfect platform to discuss the latest innovations in the peptides industry and explore a number of pressing issues such as the use of Cell Penetrating Peptides (CPP), the challenges involved with oral peptides and novel technologies for development and improvement.
Plus 2 interactive pre-conference workshops:
A: Cyclic Peptides - Discovery, Development and Deployment
B: Cupid Cell-Penetrating Peptides - a powerful new tool for cellular research
Early Bird Discounts:
Book by 31st March and save £500.
Book by 29th April and save £300.
Book by 27th May and save £200.
Book by 31 March: GBP 999
Book by 29 April: GBP 1199
Book by 27 May: GBP 1299
Standard Conference Only: GBP 1499
Standard Conference + 2 workshops: GBP 2697
Standard Conference + 1 Workshop: GBP 2098
2 Workshops only: GBP 1198
1 Workshop only: GBP 599
Speakers: MedImmune, Sanofi-Aventis, Ipsen, Ministry of Foreign Affairs Denmark, Bicycle Therapeutics, Proxima Concepts
Sign in to add slides, notes or videos to this session